We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.22B
AUM Growth
-$94.6M
Cap. Flow
-$235M
Cap. Flow %
-19.18%
Top 10 Hldgs %
48.81%
Holding
242
New
17
Increased
38
Reduced
145
Closed
16

Sector Composition

Rank Sector Weight
1 Financials 3.73%
2 Technology 3.01%
3 Communication Services 2.08%
4 Healthcare 1.51%
5 Consumer Discretionary 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CINF icon
51
Cincinnati Financial
CINF
$27.9B
$3.91M 0.32%
45,509
-35,621
-44% -$2.94M
EFAV icon
52
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.2B
$3.85M 0.31%
53,400
-27,352
-34% -$1.92M
IWV icon
53
iShares Russell 3000 ETF
IWV
$19.6B
$3.82M 0.31%
22,890
-628
-3% -$101K
AGG icon
54
iShares Core US Aggregate Bond ETF
AGG
$138B
$3.68M 0.3%
33,776
-7,212
-18% -$773K
VGT icon
55
Vanguard Information Technology ETF
VGT
$139B
$3.59M 0.29%
143,464
-4,712
-3% -$109K
PEP icon
56
PepsiCo
PEP
$185B
$3.34M 0.27%
27,231
-3,085
-10% -$352K
CVX icon
57
Chevron
CVX
$378B
$3.15M 0.26%
25,565
-5,372
-17% -$636K
IBDL
58
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
-120,000
Closed -$3.02M
JPM icon
59
JPMorgan Chase
JPM
$901B
$3.1M 0.25%
30,620
-2,552
-8% -$263K
IBDP
60
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
-124,429
Closed -$3.03M
IBDO
61
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
-123,355
Closed -$3.03M
IBDN
62
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
-123,203
Closed -$3.03M
IBDM
63
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
-123,102
Closed -$3.02M
SCHM icon
64
Schwab US Mid-Cap ETF
SCHM
$14.5B
$3.01M 0.25%
163,080
-41,313
-20% -$738K
GOOG icon
65
Alphabet (Google) Class C
GOOG
$4.29T
$2.99M 0.24%
50,940
-2,180
-4% -$122K
DIS icon
66
Walt Disney
DIS
$167B
$2.96M 0.24%
26,672
+2,487
+10% +$278K
VCIT icon
67
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.5B
$2.8M 0.23%
32,224
-6,170
-16% -$523K
IWR icon
68
iShares Russell Mid-Cap ETF
IWR
$56.5B
$2.76M 0.23%
51,251
-8,999
-15% -$466K
RY icon
69
Royal Bank of Canada
RY
$292B
$2.76M 0.23%
36,500
-36,500
-50% -$2.76M
SCHZ icon
70
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$2.71M 0.22%
104,386
-17,100
-14% -$436K
MMM icon
71
3M
MMM
$83B
$2.67M 0.22%
15,394
+4,880
+46% +$822K
IYY icon
72
iShares Dow Jones US ETF
IYY
$2.94B
$2.67M 0.22%
37,748
UNP icon
73
Union Pacific
UNP
$176B
$2.66M 0.22%
15,894
-1,778
-10% -$286K
TJX icon
74
TJX Companies
TJX
$172B
$2.44M 0.2%
45,710
-5,266
-10% -$263K
ABT icon
75
Abbott
ABT
$177B
$2.15M 0.18%
26,863
-4,722
-15% -$351K

Similar funds

Aspiriant LLC's Q1 2019 Portfolio in Review

As of Q1 2019, Aspiriant LLC held 242 positions worth $1.22B, down 7.2% from $1.32B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Aspiriant LLC withdrew a net $235M in Q1 2019, closing 16 positions and reducing 145 holdings. Its most notable exit was iShares iBonds Dec 2024 Term Corporate ETF, an estimated $3.03M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.7% of assets, down from 4.1% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Aspiriant LLC opened a new position in Vanguard Total World Stock ETF worth $4.05M.

  • Aspiriant LLC's largest Q1 2019 buy was Vanguard Total World Stock ETF: 55,319 shares worth $4.05M.
  • Aspiriant LLC added most to Vanguard Global ex-US Real Estate ETF in Q1 2019, an estimated $4.58M increase.
  • Aspiriant LLC's biggest Q1 2019 reduction was NYLI Hedge Multi-Strategy Tracker ETF, cutting an estimated $50.6M.
  • Aspiriant LLC fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q1 2019, selling an estimated $3.03M.
  • Aspiriant LLC's ten largest holdings make up 49% of its $1.22B portfolio in Q1 2019.
  • Aspiriant LLC opened 17 new positions and closed 16 in Q1 2019.
  • Aspiriant LLC's portfolio value fell 7.2% quarter-over-quarter to $1.22B.

Based on Aspiriant LLC's 13F filing for Q1 2019, filed 3 May 2019.